Videos
Description:
High-level overview of autologous stem cell transplant (ASCT) for treatment of multiple myeloma.
Module Objectives:
- Review concepts of who should undergo an ASCT, eligibility and treatment decision making
- Provide a brief overview of the…
Myeloma Made Simple: Treatment for Patients Not Undergoing Transplant (Non-ASCT Transplant Eligible)
Videos
Treatment for Patients Not Undergoing Transplant Made Simple
Myeloma Made Simple: Non-ASCT Transplant Eligible
Treatment for Patients Not Going to Transplant Made Simple! Join Dr. Joseph Mikhael in the latest episode of "Myeloma Made Simple" as he discusses effective therapies…
Videos
Bispecific Antibodies: Late Side Effects
Side effects to look out for in the later stages of bispecific treatment
Tune in to this video to see IMF Chief Medical Officer Dr. Joseph Mikhael break down the late side effects of bispecific antibodies, including infections, low white…
News Article
On September 26, 2023, the City of Glendale in Los Angeles County awarded a proclamation to the International Myeloma Foundation for Blood Cancer Awareness Month.
.video-responsive{
overflow:hidden;
padding-bottom:56.25%;
position:relative;
height:0;
}
.video-responsive iframe{…
Page
Phase I Clinical Trial The main goal of a phase I clinical trial is to determine the maximum tolerated dose (MTD) and safety profile of a new drug or a new combination of drugs. A phase I study may be the first testing of a new treatment in humans. However, when it comes to combination…
Page
Historically, clinical trials have lacked diverse representation in general and in myeloma clinical trials in particular. In the U.S., approximately 20% of all myeloma patients are of African descent, but only 5%–8% of patients in myeloma clinical trials are of African descent. Why Diversity…
Videos
M-Power Tampa Community Event On Health Empowerment.
Focusing on awareness of multiple myeloma in the African American community and living a healthier life.
The M-Power Project realizes the IMF Diversity Initiative's vision, enhancing outcomes for African-American myeloma patients. Though…
Page
Philanthropic contributions of any size and frequency support’s IMF’s ability to take the long road and invest in innovative research that can make a significant life-changing difference in the lives of myeloma patients, their caregivers, and other loved ones. Your gift can be a one-time monthly or…
Videos
Bispecific Antibodies: Early Side Effects
Side effects to look out for within the first month of bispecific treatment
Dr. Joseph Mikhael, IMF Chief Medical Officer, guides viewers through the side effects they can expect within the first month of bispecific myeloma treatment.…
News Article
IMF President and CEO Yelak Biru attended a policy summit in Washington, D.C., where he along with a National Comprehensive Cancer Network (NCCN) working group presented new recommendations for measuring and addressing health-related social needs (HRSN) for people with cancer. Learn more at…
Videos
Using Different Targets to Destroy Multiple Myeloma
How Bispecifics Attach to Myeloma Cells
Join Dr. Joseph Mikhael, IMF Chief Medical Officer, to learn how different bispecific antibodies work to destroy myeloma by attaching to antigens on myeloma cells.
News Article
According to a September 11, 2023 press release from BioLineRx Ltd. (NASDAQ/TASE: BLRX), a commercial stage biopharmaceutical company focused on certain cancers and rare diseases, the U.S. FDA "has approved APHEXDA™ (motixafortide) in combination with filgrastim (G-CSF) to mobilize hematopoietic…
News Article
NEW ORLEANS, September 7, 2023 — The International Myeloma Foundation (IMF), in partnership with the National Medical Association (NMA), the W. Montague Cobb Institute, and the Student National Medical Association (SNMA), sent a delegation of eleven IMF Medical Student Scholars for…
IMF Person
Sanjay Singh is a global finance and strategy leader who leverages his broad financial expertise to shape and influence business strategy and drive transformation. He is currently a Consultant and Board Member. He has worked as a Chief Financial Officer and Senior VP for Business Planning and…
IMF Person
Diagnosed with multiple myeloma in 1989 at age 33, Brian D. Novis founded the IMF in 1990, along with wife Susie, and Brian’s then-physician, Dr. Brian G.M. Durie. Together, the three join forces and set out to educate patients about the little-known blood cancer and available treatment options…
Videos
Monoclonal Antibodies Made Simple
Myeloma Made Simple: Approved Therapies For Myeloma Treatment
Monoclonal Antibodies Made Simple! Discover the power of immunotherapy in fighting multiple myeloma in the latest episode of Myeloma Made Simple with Dr. Joseph Mikhael. Learn how…
Videos
During Extreme Weather Patterns, Myeloma Patients Should Take Extra Precautions
In this week's "Ask Dr. Durie" myeloma expert Dr. Brian G.M. Durie discusses the importance of having essential medications, including antibiotics, readily available and other backup plans in case of…
News Article
LOS ANGELES, AUGUST 31, 2023 - The International Myeloma Foundation (IMF) announced today that global leader and patient advocate Emma Hatcher has been named as the IMF’s Global Vice President of Patient Engagement & Advocacy. This hire is one of many strategic investments…
News Article
Empowering Patients and Care Partners
Update on the Safe Step Act and the HELP Copays Act
By Danielle Doheny, IMF Director, Public Policy & Advocacy
The journey of a patient with myeloma can be complicated. I know this from being a part of my dad’s…
News Article
In this interview, Dr. Joseph Mikhael, Chief Medical Officer of the International Myeloma Foundation, sheds light on strategies to tackle the historical lack of diversity in…
News Article
Collaboration between researchers and organizations is crucial for addressing the persistent disparities in access to treatments for multiple myeloma (MM), according to IMF Chief Medical Officer Joseph Mikhael, MD, MEd, FRCPC, FACP.…
News Article
Nurse Leadership Board Symposium at the 2023 ONS Congress
The IMF’s nurse leaders educate peers to improve the lives of patients with myeloma
By Diane Moran, IMF Senior Vice President, Business Relationship Management
On April 27, the IMF Nurse…
News Article
LOS ANGELES, AUGUST 24, 2023 – In 2010, the U.S. Congress designated September as Blood Cancer Awareness Month to create awareness, increase fundraising, and support patients affected by all types of blood cancers.
For Blood Cancer Awareness Month 2023, the International…
Videos
Myeloma Patients May Face Various Challenges That Can Disrupt Their Sleep Patterns
In this week's "Ask Dr. Durie" myeloma expert Dr. Brian G.M. Durie discusses the various challenges that can disrupt sleep patterns, such as pain management, GI issues, and worry/anxiety about treatment and future…
News Article
TALVEY® (talquetamab), a bispecific antibody that targets GPRC5D, has shown promising results in the treatment of relapsed and refractory multiple myeloma (RRMM). The European Commission has granted conditional marketing authorization for TALVEY® (talquetamab) as a monotherapy for adult patients…
Videos
CAR T-cell Therapy and Bispecific Monoclonal Antibodies Come with Potential Side Effects
In this week's “Ask Dr. Durie” video, multiple myeloma expert Dr. Brian G.M. Durie discusses CAR T-cell therapy and bispecific monoclonal antibodies and their potential side effects such as immune…
News Article
The International Myeloma Foundation Honors Two Outstanding Researchers
Congratulations to Dr. María-Victoria Mateos and Dr. Thomas Martin
Each year, the IMF honors two outstanding researchers who have made significant contributions in the field of myeloma. On June 8, the IMF…
News Article
LOS ANGELES, AUGUST 17, 2023 - The International Myeloma Foundation (IMF) announced today that Visionary and Strategic Fundraiser Sylvia Dsouza, MPA has been named as the IMF’s Vice President of Philanthropy.
Prior to joining the IMF, Dsouza was the Senior Executive…
Videos
Michael Tuohy: A 23-Year Survivor's Journey Living with Multiple Myeloma
Join Michael Tuohy, a resilient 23-year survivor of multiple myeloma, and his dedicated care partner, Robin Tuohy, as they share their inspiring experience living with the disease. In this heartfelt…
Videos
Nick Lenoir Shares How He Balances Myeloma Treatment While Being a Dad
In Memoriam
During his life, Nick Lenoir made every attempt to share his story of his multiple myeloma journey to give hope to others in the community. In this video, Nick shares his inspiring journey. Balancing work…
News Article
According to an August 14, 2023 press release, Pfizer announced that the "U.S. Food and Drug Administration (FDA) has granted accelerated approval to ELREXFIO™ (…
News Article
In this August 10, 2023 press release, the Janssen Pharmaceutical Companies of Johnson & Johnson announced that "the U.S. Food and Drug Administration (FDA) has granted accelerated approval of TALVEY™ (talquetamab-tgvs), a first-in-class bispecific antibody for the treatment of adult patients…
Page
The Virtual Tissue Bank (VTB) is a combined research project of the IMF’s International Myeloma Working Group (IMWG) and Asian Myeloma Network (AMN) with Prof Wee Joo Chng piloting the project for AMN in Singapore at the National University Cancer Institute and Dr. Thomas Martin leading the global…
Page
What is the IMF’s Immune Therapy Registry?
The Immune Therapy Registry, an International Myeloma Working Group (IMWG) research project, is the first global clinical database study to prospectively collect data from patients with relapsed and/or high-risk myeloma receiving immune therapies. Data…
Page
The 2022 Susie Novis Durie (SND) Educational Grants
One of the ways GMAN accomplishes its mission is by awarding Susie Novis Durie (SND) Educational Grants to patient advocacy organizations to elevate their work. Here are the 2022 SND Grant Recipients:
Australia (Better Care for Younger…
News Article
2023 ASCO and EHA Abstracts Explained
Bispecifics, CAR T-cell therapy, and more!
In June 2023, a large number of myeloma research abstracts were presented by pre-eminent experts at the annual congresses of the American Society of Clinical Oncology (ASCO) and the European…
Videos
Drug Classes Made Simple
Myeloma Made Simple: The Main Types of Drugs Used to Treat Myeloma
Join Dr. Joseph Mikhael, Chief Medical Officer of the International Myeloma Foundation, as he simplifies the complexities of drug classes for myeloma patients. Learn about the mechanisms…
Videos
The International Myeloma Foundation’s Black Swan Research Initiative Is Creating the Science Behind the Cures for Myeloma
In this week's “Ask Dr. Durie”, multiple myeloma expert Dr. Brian G.M. Durie discusses the International Myeloma Foundation's signature research project, the Black…
News Article
Jack Aiello and Sanjay Singh Elected to IMF's Board of Directors
Meet the IMF's newest board members
The International Myeloma Foundation (IMF) recently welcomed two new members to the Board: Myeloma Support Group Leader and 28-year myeloma survivor Jack Aiello, and Global…
News Article
LOS ANGELES, JULY 27, 2023 - The International Myeloma Foundation (IMF) today welcomed two of its newest Board Members: Myeloma Support Group Leader and 28-year myeloma survivor Jack Aiello, and Global Finance and Strategy Leader and 2-year myeloma survivor Sanjay Singh. …
News Article
On July 26, 2023, LatentView Analytics, a global digital analytics consulting and solutions firm, released a press release about their collaboration with the International Myeloma Foundation (IMF). According to this press release, the IMF will "leverage data for the greater good of society and…
News Article
In this press release, the Janssen Pharmaceutical Companies of Johnson & Johnson announces “the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended conditional marketing authorization (CMA) for TALVEY® (talquetamab) as monotherapy for the…
Videos
The International Myeloma Foundation's Global Myeloma Action Network Summit
The 2023 Global Myeloma Action Network (GMAN) Summit took place in Frankfurt, Germany, where 30 patient organization representatives from 5 continents gathered to enhance the capabilities of patient advocacy groups…
News Article
Current Chairman of the Board of Directors Brian G.M. Durie, MD will not seek re-election for 2024 term
LOS ANGELES, JULY 20, 2023 - The International Myeloma Foundation (IMF) today announced that world-renowned myeloma clinician and researcher S. Vincent Rajkumar, MD…
Videos
Myeloma University: Selinexor and Venetoclax
Two drugs used to treat relapsed multiple myeloma
Description:
Review the newer drugs used to treat multiple myeloma in a relapse setting: selinexor and venetoclax.
Module Objectives:
-…
Videos
Myeloma University: Steroids, IMiDs, and PIs
Learn about the three classes of drugs used to treat multiple myeloma
Description:
Learn about steroids, IMiDs, and PIs: three classes of drugs used to treat multiple myeloma.
Module Objectives:…
Videos
Myeloma University: Treatment Selection
Learn about treatment selection in upfront and relapse settings
Description:
Learn the basics of treatment selection in upfront and relapse settings as well as the importance of disease…
Videos
The IMF Medical Scholars for Health Equity in Myeloma Mentorship Program
The International Myeloma Foundation (IMF) has partnered with the W. Montague Cobb/NMA Health Institute’s Cobb Scholars Program to develop a mentoring program for African American medical school students.
Twelve students…